Take a sneak peek at the new NIST.gov and let us know what you think!
(Please note: some content may not be complete on the beta site.).

View the beta site
NIST logo
Bookmark and Share

2010 Maryland Stem Cell Research Symposium


Maryland TEDCO and Maryland Stem Cell Research Fund has partnered with NIST, NIH, Johns Hopkins University, and the University System of Maryland to create the most up to date symposium on stem cell research that will facilitate State and Federal collaboration to advance groundbreaking life science research.

The meeting will be a scientific research symposium with scientific presentations and poster sessions. It will be open to the scientific community and the general public to allow them to view the resarch supported by the Maryland Stem Cell Research Fund and Federal agencies.


Morning Agenda

7:00am - 8:00am

Breakfast / Registration

Opening remarks:


8:00am - 8:30am


Dan Gincel, MSCRF Director

Dr. Willie E. May,Director, Chemical Science and Technology    Laboratory  CSTL, NIST

Story Landis, NINDS Director

Margaret Conn Himelfarb, Chair Maryland Stem Cell Research Commission


Hematopoietic and Mesenchymal Stem Cells

8:30am - 10:00am


Moderator: Dr. Curt Civin

 ·         Curt Civin, UMB:MicroRNA Maestros of Hematopoiesis and Leukemia

·         Pam Robey, NIH:The Biology of skeletal Stem Cells and their utility in Regenerative medicine.

·         Elias Zambidis, JHU: Generation of Hematopoietic and cardiac lineages from nonviral clinically-safe human induced pluripotent stem cells



·         Poster teasers

·         Panel discussion and questions at the end of the session


10:00am - 10:30am

Break and Poster Viewing

Induced Pluripotent Stem Cells

10:30am - 12:00pm


Moderator: Dr. Pam Robey


·         Josh Chenoweth, NIH:Controlling Stem Cells in Health and Disease

·         Manfred Boehm, NIH:

·         Linzhao Cheng, JHU: Human iPS cells: Gene Targeting and Blood Disease Modeling



·         Poster teasers

·         Panel discussion and questions at the end of the session

Afternoon Agenda

12:00pm - 1:45pm

Lunch and Poster Viewing

The John L. Kellermann III Memorial Lecture

1:45pm - 2:30pm

Ted Dawson, JHU: Generation and Characterization of Human iPScells from Sporadic and Genetic PD and Control Patients

Stem Cells and Neurodegenerative Diseases

2:30pm - 4:00pm


Moderator: Dr. Jeffery Rothstein


·         Jeffery Rothstein, JHU: Gliogenic Small Molecules – Stem Cell Therapy without Exogenous Stem Cells

·         Nick Maragakis, JHU: Glial Progenitor Cells as Tools for Understanding and Potentially Treating Motor Neuron Disease



·         Poster teasers

·         Panel discussion and questions at the end of the session

4:00pm - 4:30pm

Break and Poster Viewing

Clinical Trial in Stem Cells

4:30pm - 6:00pm


Moderator: Dr. Laure Aurelian


·         Donald W. Fink, FDA/CBER: Clinical Translation of Stem Cell-based Therapies: FDA Basis Principles

·         Laure Aurelian, UMB: Herpes Simplex Virus Induces Stem Cell Differentiation and Graft vs. Host Disease (GVHD) in Bone Marrow Transplant Patients

·         Randal Mills, OSIRIS:

·         Mark Vesely, UMB: Intravenous Human Mesenchymal Stem Cells following Acute Myocardial Infarction


·         Poster teasers

·         Panel discussion and questions at the end of the session


6:00pm - 7:30pm

Reception, Networking and Poster Viewing

Security Instructions:

Registration will be required for everyone.
If you are not registered you will not be allowed on site.


See draft program.


Start Date: Wednesday, September 22, 2010
End Date: Wednesday, September 22, 2010
Location: NIST, Gaithersburg, MD
Audience: Industry, Government, Academia
Format: Symposium


Maryland Stem Cell Research Fund (MSCRF)
Maryland Technology Development Corporation (TEDCO)
National Institute of Standards and Technology (NIST)
National Institutes of Health (NIH), HHS



Maryland Stem Cell Research Symposium Save-the-Date

The 3rd Annual Maryland Stem Cell
Research Symposium, September 22, 2010.
Credit: Maryland Stem Cell Research Fund (MSCRF)